scispace - formally typeset
C

Corrado Vassanelli

Researcher at University of Verona

Publications -  216
Citations -  5966

Corrado Vassanelli is an academic researcher from University of Verona. The author has contributed to research in topics: Coronary artery disease & Myocardial infarction. The author has an hindex of 35, co-authored 216 publications receiving 5564 citations. Previous affiliations of Corrado Vassanelli include University of Eastern Piedmont & Utrecht University.

Papers
More filters
Journal ArticleDOI

Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials.

TL;DR: A clear ongoing trend toward equalization of the two procedures, in terms of procedural success, is evident through the years, probably due to technologic progress of materials and increased operator experience.
Journal ArticleDOI

Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOC trial

TL;DR: Palaz-Schatz stent implantation after successful balloon PTCA of chronic total occlusions improves the midterm angiographic and clinical outcome and could be the preferred treatment option in selected patients with occluded vessels.
Journal ArticleDOI

Myocardial bridges and ischemic heart disease

TL;DR: The clinical, electrocardiographs and angiocardiographic data are reported of 37 patients with myocardial bridges, in the absence of coronary atherosclerosis; one patient died suddenly the day following hospital discharge; of 27 patients followed over a 3–36 month interval, only four were free of symptoms on medical treatment.
Journal ArticleDOI

Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure.

TL;DR: This treatment gives evidence that myocardial energy, endothelial dysfunction, and vasodilator reactivity to exercise are improved by reducing markers of oxidative stress responsible for vascular dysfunction, so it represents an interesting therapeutic alternative for better outcome in CHF patients.